期刊
CLINICAL INFECTIOUS DISEASES
卷 69, 期 -, 页码 519-520出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciz823
关键词
cefiderocol; cephalosporin; carbapenem-resistant Enterobacteriaceae; nonfermenting gram-negative bacteria; siderophore
资金
- Shionogi & Co, Ltd (Osaka, Japan)
Cefiderocol, a novel siderophore cephalosporin in late-stage clinical development, utilizes a Trojan horse active transport mechanism to enter bacteria and has proven in vitro activity against carbapenem-resistant gram-negative pathogens, including those with major carbapenem-resistance mechanisms, and stability against all carbapenemases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据